Cost-effectiveness of detemir-based basal/bolus therapy versus NPH-based basal/-bolus therapy for Type 1 diabetes in a UK setting. An economic evaluation based on a meta-analysis of four clinical trials

被引：0
|
作者：
Roze, S
Palmer, AJ
Valentine, WJ
Smith, IC
Wittrup-Jensen, K
机构：
[1] CORE, Ctr Outcomes Res, Dept Stat, Binningen, Switzerland
[2] CORE, Ctr Outcomes Res, Dept Hlth Econ & Modelling, Binningen, Switzerland
[3] CORE, Ctr Outcomes Res, Dept Med Writing, Binningen, Switzerland
[4] Novo Nordisk Ltd UK, Regulatory Dept, Crawley, England
[5] Novo Nordisk AS, Global Dev Hlth Econ & Outcomes Res, DK-2880 Bagsvaerd, Denmark
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
960
引用
收藏
页码：A345 / A345
页数：1
相关论文
共 40 条
  • [21] Evaluation of the Short-Term Cost-Effectiveness of IDegLira Versus Basal Insulin and Basal-Bolus Therapy in Patients with Type 2 Diabetes Based on Attainment of Clinically Relevant Treatment Targets
    Cannon, Anthony J.
    Bargiota, Alexandra
    Billings, Liana
    Hunt, Barnaby
    Leiter, Lawrence A.
    Malkin, Samuel
    Mocarski, Michelle
    Ranthe, Mattis Flyvholm
    Schiffman, Alisa
    Doshi, Ankur
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2020, 26 (02): : 143 - 153
  • [22] Comparison of the cost-effectiveness for basal-bolus therapy of type-1 diabetes using insulin detemir plus insulin aspart or human insulin-based regimens in the Netherlands
    Valentine, WJ
    Wittrup-Jensen, K
    Palmer, AJ
    Roze, S
    VALUE IN HEALTH, 2005, 8 (03) : 255 - 255
  • [23] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    K. Hermansen
    P. Fontaine
    K. K. Kukolja
    V. Peterkova
    G. Leth
    M.-A. Gall
    Diabetologia, 2004, 47 : 622 - 629
  • [24] Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal-bolus therapy for patients with Type 1 diabetes
    Hermansen, K
    Fontaine, P
    Kukolja, KK
    Peterkova, V
    Leth, G
    Gall, MA
    DIABETOLOGIA, 2004, 47 (04) : 622 - 629
  • [25] GLP-1 receptor agonist added to insulin versus basal-plus or basal-bolus insulin therapy in type 2 diabetes: A systematic review and meta-analysis
    Castellana, Marco
    Cignarelli, Angelo
    Brescia, Francesco
    Laviola, Luigi
    Giorgino, Francesco
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2019, 35 (01)
  • [26] Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Dario Giugliano
    Paolo Chiodini
    Maria Ida Maiorino
    Giuseppe Bellastella
    Katherine Esposito
    Endocrine, 2016, 51 : 417 - 428
  • [27] Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Giugliano, Dario
    Chiodini, Paolo
    Maiorino, Maria Ida
    Bellastella, Giuseppe
    Esposito, Katherine
    ENDOCRINE, 2016, 51 (03) : 417 - 428
  • [28] Cost-effectiveness analyses of basal-bolus therapy of type-1 diabetes using insulin detemir plus human soluble insulin versus neutral protamine hagedorm plus human soluble insulin regimens in Germany
    Valentine, WJ
    Palmer, AJ
    Wittrup-Jensen, KU
    Roze, S
    VALUE IN HEALTH, 2005, 8 (06) : A163 - A163
  • [29] Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden
    Valentine, William J.
    Aagren, Mark
    Haglund, Mattias
    Ericsson, Asa
    Gschwend, Manuela H.
    SCANDINAVIAN JOURNAL OF PUBLIC HEALTH, 2011, 39 (01) : 79 - 87
  • [30] LONG-TERM COST-EFFECTIVENESS OF IDEGLIRA VERSUS BASAL-BOLUS INSULIN AS INTENSIFICATION THERAPIES FOR PEOPLE WITH TYPE 2 DIABETES INADEQUATELY CONTROLLED ON BASAL INSULIN IN SPAIN: PROJECTIONS BASED ON THE DUAL VII TRIAL
    Ampudia, F. J.
    Mezquita, P.
    de Arellano, Ramirez A.
    Basse, A.
    Hunt, B.
    VALUE IN HEALTH, 2017, 20 (09) : A480 - A480
1234